Abstract:BackgroundAarskog-Scott syndrome, a rare X-linked genetic disorder, is identified by combined clinical manifestations of short stature, facial, skeletal, and genital anomalies. Annually, two or three new cases are diagnosed with Aarskog-Scott syndrome, which is associated with FGD1 variants. However, there is no specific treatment for Aarskog-Scott syndrome due to its unclear mechanism. MethodsClinical data were collected when the patient first visited the hospital. Trio whole-exome sequencing and Sanger sequencing were performed for the genetic cause of disease. To evaluate the pathogenicity of the variants in vitro, stable cell lines were constructed using lentivirus infection in 143B cell. Furthermore, Western blot was used to verify the expression of signaling pathway-related proteins, and the transcription levels of osteogenic-related genes were verified by luciferase reporter gene assay. ResultsA 7-year-old boy was manifested with facial abnormalities, intellectual disability, and short stature (-3.98 SDS) while the growth hormone level of stimulation test was normal. Trio whole-exome sequencing and Sanger sequencing identified a variant (c.1270A>G, p.Asn424Asp) in FGD1 gene. The Asn424 residue was highly conserved and the hydrogen bond in the FGD1 variant protein has changed, which led to decrease in the interaction with CDC42 protein. In vitro study showed that the Asn424Asp variant significantly decreased the transcription levels of OCN, COL1A1, and ALP activity, and it activated the phosphorylation of JNK1. ConclusionMolecular biological mechanisms between abnormal expression of FGD1and Aarskog-Scott syndrome remain poorly understood. In our study, c.1270A>G variant of FGD1 resulted in Aarskog-Scott syndrome, and the analysis of pathogenicity supports the deleterious effect of the variant. Furthermore, we demonstrated the weakened affinity of the mutant FGD1 and CDC42. Decreased expression of osteogenic-related gene and abnormal activation of JNK1 were also shown in this work.

National guidelines are needed to provide sanitary facilities in primary schools

A missense, loss-of-function YARS1 variant in a patient with proximal-predominant motor neuropathy

Clinical and Genetic Analysis of Essential Hypertension with Mitochondrial Trnamet 4435A>G and YARS2 Mutation.

Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review.

Four pedigrees with aminoacyl-tRNA synthetase abnormalities

Bi‐allelic mutations in HARS1 severely impair histidyl‐tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome

A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations

Expanded phenotype of AARS1-related white matter disease

Early-onset dysphagia and severe neurodevelopmental disorder as early signs in a patient with two novel variants in NARS1: a case report and brief review of the literature

Hearing Impairment-Associated KARS Mutations Lead to Defects in Aminoacylation of Both Cytoplasmic and Mitochondrial Trna Lys

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

FGD1 Variant Associated with Aarskog–Scott Syndrome

WARS1 and SARS1 : Two Trna Synthetases Implicated in Autosomal Recessive Microcephaly

The Aggravation of Neuropsychiatric Symptoms in the Offspring of a Korean Family with Intellectual Disability and Developmental Delay Caused by a Novel ARX p.Lys385Ter Variant

Alanyl-transfer ribonucleic acid synthetase 2 gene mutation producing leukodystrophy: a case report

A novel mutation in EYA1 in a Chinese family with Branchio-oto-renal syndrome

Case Report: Late-Onset Autosomal Recessive Cerebellar Ataxia Associated With SYNE1 Mutation in a Chinese Family

Comprehensive assessment of recessive, pathogenic AARS1 alleles in a humanized yeast model reveals loss-of-function and dominant-negative effects

A model organism pipeline provides insight into the clinical heterogeneity of TARS1 loss-of-function variants

Distinct Magnetic Resonance Imaging Features in a Patient with Novel RARS2 Mutations: A Case Report and Review of the Literature.

Case Report: DARS Mutations Responsible for Hypomyelination With Brain Stem and Spinal Cord Involvement and Leg Spasticity